Breaking News
Get 50% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI
Close

Calidi Biotherapeutics Inc (CLDI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Calidi Biotherapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
5.0100 -0.7500    -13.02%
08/08 - Closed. Currency in USD
After Hours
5.1500
+0.1400
+2.7944%
0:59:16 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 166,271
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 5.0000 - 5.7566
Calidi Biotherapeutics 5.0100 -0.7500 -13.02%

Calidi Biotherapeutics Inc Company Profile

 
Get an in-depth profile of Calidi Biotherapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

28

Equity Type

ORD

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.

Contact Information

Address 4475 Executive Drive Suite 200
San Diego, 92121
United States
Phone 858 794 9600
Fax 858 794 9605

Top Executives

Name Age Since Title
W.K. Alfred Yung - 2022 Member of Medical Advisory Board
Scott Leftwich 64 2019 Independent Vice-Chairman of the Board
E. Antonio Chiocca - - Member of Medical & Scientific Advisory Board
Mark Gilbert - 2024 Member of Medical & Scientific Advisory Board
David T. Curiel - - Member of Medical & Scientific Advisory Board
Burt L. Nabors - - Member of Medical & Scientific Advisory Board
George E. Peoples 62 2024 Independent Director
Dmitriy Zamarin - 2021 Member of Scientific Advisory Board
Santosh Kesari - - Member of Medical Advisory Board
Karen Aboody - - Member of Medical Advisory Board
Maciej S. Lesniak - - Member of Medical Advisory Board
Alan R. Stewart 61 2023 Independent Director
Ashok Srivastava - - Member of Scientific Advisory Board
Ewa K. Carrier - - Member of Medical Advisory Board
Allan J. Camaisa 64 2018 Director
James A. Schoeneck 67 2020 Independent Chairman of the Board
Eric E. Poma 53 2025 CEO & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CLDI Comments

Write your thoughts about Calidi Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email